Clinical Trials Management, LLC

1. Celgene Corporation $155,454 14 payments
2. Bausch Health US, LLC $116,345 15 payments
3. Sun Pharmaceutical Industries Inc. $88,329 43 payments
4. Exeltis, USA Inc. $69,284 3 payments
5. Taro Pharmaceuticals USA, Inc. $19,911 4 payments
6. Amgen Inc. $14,268 2 payments
7. Organon LLC $6,500 1 payment
8. E.R. Squibb & Sons, L.L.C. $2,895 1 payment
9. Ironwood Pharmaceuticals, Inc $2,060 2 payments
10. Kowa Research Institute, Inc. $924 1 payment

1. A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of Idp-126 Gel to Epiduo? Forte Gel (0.3% Adapalene/2.5% Bpo), in the Treatment of Acne Vulgaris $116,345 15 payments
2. RXLC 2118 $96,812 29 payments
3. A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability ofLPRI-424, 13 Cycles $64,653 2 payments
4. Phase III CC-93538 Treat-Through (CC-93538-EE-001) Wk24 PE Primary - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolesc $62,408 3 payments
5. Phase III Study - Long Term Extension/Rollover from EE-001 - A Phase 3, Multi-Center, Multi-National, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Active Eosinophilic Esophagiti $54,821 5 payments
6. A Phase 3, Multi-Center, Multi-National, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Active Eosinophilic Esophagitis. $15,850 2 payments
7. A Multi-Center, Multi-National, Randomized, Double - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects wit $13,524 1 payment
8. A Study of the Efficacy and Safety of Apremilast CC-10004 in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp STYLE $9,409 1 payment
9. Phase 3 EOE Registrational - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Active Eosinophilic Es $7,908 1 payment
10. Og-6219-P001 $6,500 1 payment

1. Patient care $6,500 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.